Approval · Notice of Compliance 9352 · 2008
ACYCLOVIR SODIUM INJECTION: Notice of Compliance 9352
Issued February 4, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9352
- Date
- February 4, 2008
- Company
- Pharmaceutical Partners Of Canada IncRichmond Hill, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antiviral agent
- Canadian reference product
- ZOVIRAX (Glaxo Wellcome Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACYCLOVIR SODIUM INJECTION | 02236926 | Marketed |
Medicinal ingredients
- ACYCLOVIR SODIUM 50 MG per ML